Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Epilepsia Open|August 30, 2025
Effectiveness and safety of early add-on therapy with brivaracetam in patients with poorly controlled focal seizures in routine clinical practice: BRIV-add studyPedro J Serrano-Castro, Fernando Caballero-Martínez, Francisco J Campos-Lucas, et al.
Epilepsy & Behavior : E&B|April 11, 2021
Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic reviewBernhard J Steinhoff, Pavel Klein, Henrik Klitgaard, et al.
Epilepsy & Behavior : E&B|April 5, 2026
Development of a deep learning tool to detect drug-resistance epilepsy with EEGManuel Alanís-Bernal, José Ramón Vélez-Rodríguez, Daniel Campos-Fernández, et al.
Epilepsy & Behavior : E&B|April 18, 2026
Peri-ictal magnetic resonance imaging abnormalities during status epilepticus in adults with idiopathic generalized epilepsyAndrea Enerstad Bolle, Silvana Sarria-Estrada, Thomas Bonduelle, et al.
Epilepsy & Behavior : E&B|June 17, 2020
Emergency implementation of telemedicine for epilepsy in Spain: Results of a survey during SARS-CoV-2 pandemicEstefanía Conde-Blanco, María Centeno, Ester Tio, et al.
Medicina Clinica|May 23, 2025
Treatment administration during a seizure in home-settings: Time to treat (TT)Manuel Toledo, Irene García Morales, José María Serratosa, et al.
Epilepsia|July 2, 2019
Use of intravenous brivaracetam in status epilepticus: A multicenter registryEstevo Santamarina, Beatriz Parejo Carbonell, Jacint Sala, et al.
Brain Communications|November 26, 2020
Padsevonil randomized Phase IIa trial in treatment-resistant focal epilepsy: a translational approachPierandrea Muglia, Jonas Hannestad, Christian Brandt, et al.
European Stroke Journal|April 1, 2024
Exploratory study of blood biomarkers in patients with post-stroke epilepsyLaura Abraira, Samuel López-Maza, Manuel Quintana, et al.
Pageof 13